MARKET

LMNX

LMNX

Luminex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

36.64
-0.14
-0.38%
Closed 16:00 05/11 EDT
OPEN
36.56
PREV CLOSE
36.78
HIGH
36.87
LOW
36.56
VOLUME
857.22K
TURNOVER
--
52 WEEK HIGH
41.69
52 WEEK LOW
20.61
MARKET CAP
1.73B
P/E (TTM)
113.54
1D
5D
1M
3M
1Y
5Y
Global Meningitis Diagnostic Testing Market 2021 to 2026 - New Study, Industry Scope, and Growth Strategies
May 11, 2021 (CDN Newswire via Comtex) -- Global Meningitis Diagnostic Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026 passes...
CDN Newswire · 16h ago
Multiplex Assays Market: Global Development Strategy Analysis 2021 By Industry Size, Share, Trending Technologies, Top Manufactures, Business Statistics, Regional Analysis and Growth till 2026
May 11, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The “Multiplex Assays Market” research...
The Express Wire · 17h ago
COVID-19 Diagnostics Market Size, Share, Trends, Analysis and Forecast 2027
May 11, 2021 (Market Insight Reports) -- The Global COVID-19 Diagnostics Market is poised to value over USD 104.5 billion by 2027 end at a CAGR of over 3.1%...
Market Insight Reports · 18h ago
Luminex Corp Up 52.9% Since SmarTrend Uptrend Call (LMNX)
May 11, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Luminex Corp (NASDAQ:LMNX) on December 1st, 2020 at $24.08. In...
marketwatch.com · 22h ago
Genetic Testing Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2027
Market Insight Reports · 23h ago
SNP Genotyping Market : Business overview, Upcoming Trends and Top Company Analysis Forecast By 2025
Japan, Japan, Fri, 07 May 2021 05:17:22 / Comserve Inc. / -- The report analyze market size, share, growth, trends, segmentation, top key players,...
Comserve · 4d ago
Life Science Tools & Reagents Market Size, Share, Industry Growing Rapidly with Recent Demand, Trends, Development, Revenue and Forecast to 2021-2025
May 07, 2021 (The Expresswire) -- Global "Life Science Tools and Reagents Market" 2021 Industry Research Report is an inside-out and expert examination on...
The Express Wire · 4d ago
Microspheres Market Share, Growth by Business Developments 2021 to 2025 – 3M, Nouryon, Chase Corp, Luminex Corporation, Matsumoto Yushi Seiyaku Co. Ltd
May 07, 2021 (Market Insight Reports) -- The Microspheres Market research report provides detailed observation of several aspects, including the rate of...
Market Insight Reports · 4d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LMNX. Analyze the recent business situations of Luminex through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LMNX stock price target is 34.50 with a high estimate of 37.00 and a low estimate of 32.00.
EPS
Institutional Holdings
Institutions: 291
Institutional Holdings: 43.02M
% Owned: 90.92%
Shares Outstanding: 47.31M
TypeInstitutionsShares
Increased
78
2.53M
New
30
1.17M
Decreased
66
3.35M
Sold Out
40
2.91M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.23%
Healthcare Equipment & Supplies
-0.50%
Key Executives
Chairman/Director
G. Walter Loewenbaum
Chairman/President/Chief Executive Officer/Director
Nachum Shamir
Chief Financial Officer/Senior Vice President - Finance/Treasurer
Harriss Currie
Senior Vice President/General Counsel/Secretary
Richard Rew
Senior Vice President/Director of Sales
Todd Bennett
Senior Vice President/Director of Marketing
Eric Shapiro
Senior Vice President/Director of Human Resources
Nancy Fairchild
Senior Vice President
Tadd Lazarus
Senior Vice President
Chuck Collins
Senior Vice President
Randall Myers
Lead Director/Independent Director
Edward Ogunro
Independent Director
Stephen Eck
Independent Director
Thomas Erickson
Independent Director
Jimmy Kever
Independent Director
Dijuana Lewis
Independent Director
Kevin McNamara
Independent Director
Kenneth Samet
Declaration Date
Dividend Per Share
Ex-Div Date
02/08/2021
Dividend USD 0.1
03/24/2021
12/07/2020
Dividend USD 0.1
12/22/2020
09/10/2020
Dividend USD 0.09
09/23/2020
05/21/2020
Dividend USD 0.09
06/17/2020
02/13/2020
Dividend USD 0.09
03/18/2020
12/05/2019
Dividend USD 0.09
12/18/2019
07/29/2019
Dividend USD 0.09
09/25/2019
05/16/2019
Dividend USD 0.06
06/19/2019
02/07/2019
Dividend USD 0.06
03/20/2019
12/06/2018
Dividend USD 0.06
12/19/2018
09/06/2018
Dividend USD 0.06
09/20/2018
05/17/2018
Dividend USD 0.06
06/21/2018
01/23/2018
Dividend USD 0.06
03/22/2018
12/07/2017
Dividend USD 0.06
12/21/2017
09/07/2017
Dividend USD 0.06
09/21/2017
05/18/2017
Dividend USD 0.06
06/21/2017
02/20/2017
Dividend USD 0.06
03/22/2017
About LMNX
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.

Webull offers kinds of Luminex Corporation stock information, including NASDAQ:LMNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LMNX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LMNX stock methods without spending real money on the virtual paper trading platform.